journal article·2020-11

Design of telmisartan-weak acid solid dispersion to improve its solubility and stability

Jeong Sun Sohn, Ji-Won Park, Dong‐Hyun Choi, Jin-Seok Choi

Publisher page

Abstract

Abstract Telmisartan (TEL), an angiotensin II receptor antagonist, is widely used for the treatment of hypertension. However, low solubility of TEL has resulted in solubilized commercial products with alkalizers. On the contrary, our study aims to improve the solubility and dissolution rate by preparing a new TEL-solid dispersion (SD) using a weak acid. The SD formulations (SD1-0, TEL-tartaric acid-Aerosil®300 in a 1:5:3 wt ratio; SD1-6, TEL-tartaric acid-Aerosil®300: IR® in a 1:5:3:1 wt ratio) showed improved dissolution (%) by 1.19-/1.08-/1.16-fold and 1.15-/1.06-/1.11-fold compared to that of Micardis® in pH 1.2/distilled water/pH 6.8, respectively. The physical properties of the SD formulations were changed, including melting points, crystallization, and chemical interaction. Moreover, these SD formulations well maintained their stability for 12 months. In conclusion, the improved solubility and dissolution (%) of TEL in the SD formulations may result in improved bioavailability and efficacy as an anti-hypertensive substance in animals.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Drug Solubulity and Delivery Systems · Crystallization and Solubility Studies · Pharmacological Effects of Natural Compounds

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (33)

Show source-provided references
1. Biopharmaceutical classification of poorly soluble drugs with respect to “enabling formulations”10.1016/j.ejps.2013.04.002 ↗
2. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs10.1016/j.drudis.2007.09.005 ↗
3. Amorphous multi-system of celecoxib improves its anti-inflammatory activity in vitro and oral absorption in rats10.1016/j.ijpharm.2018.11.050 ↗
4. Naftopidil-fumaric acid interaction in a solid dispersion system: Improving the dissolution rate and oral absorption of naftopidil in rats10.1016/j.msec.2018.10.089 ↗
5. A novel composition of ticagrelor by solid dispersion technique for increasing solubility and intestinal permeability10.1016/j.ijpharm.2018.11.038 ↗
6. Improvement of the dissolution rate and bioavailability of fenofibrate by the supercritical anti-solvent process10.1016/j.ijpharm.2019.04.051 ↗
7. Design of Coenzyme Q10 solid dispersion for improved solubilization and stability10.1016/j.ijpharm.2019.118832 ↗
8. Co-amorphous solid dispersion systems of lacidipine-spironolactone with improved dissolution rate and enhanced physical stability
9. Comparison of paclitaxel solid dispersion and polymeric micelles for improved oral bioavailability and in vitro anti-cancer effects10.1016/j.msec.2019.03.002 ↗
10. Comparison of adsorption and conjugation of Herceptin on poly (lactic-co-glycolic acid) nanoparticles–Effect on cell internalization in breast cancer cells10.1016/j.msec.2018.06.059 ↗
11. Development of PLGA micro-and nanorods with high capacity of surface ligand conjugation for enhanced targeted delivery
12. J.-S. Choi, D.-H. Lee, J.B. Ahn, S. Sim, K.-S. Heo, C.-S. Myung, J.-S. Park, Therapeutic effects of celecoxib polymeric systems in rat models of inflammation and adjuvant-induced rheumatoid arthritis, Mater. Sci. Eng. C. DOI (2020) 111042.10.1016/j.msec.2020.111042 ↗
13. Design of Cilostazol Nanocrystals for Improved Solubility
14. Development and evaluation of decorated aceclofenac nanocrystals10.1016/j.colsurfb.2016.03.022 ↗
15. Co-milling of telmisartan with poly (vinyl alcohol)–An alkalinizer free green approach to ensure its bioavailability10.1016/j.ejpb.2016.01.016 ↗
16. A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide
17. Optimal dosing characteristics of the angiotensin II receptor antagonist telmisartan10.1016/S0002-9149(99)00400-2 ↗
18. Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: improved solubility and reduced pharmacokinetic variability10.1016/j.ijpharm.2012.08.034 ↗
19. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release10.1016/j.jconrel.2008.04.001 ↗
20. Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer (s) Interactions10.1208/s12249-019-1358-3 ↗
21. Investigation of Crystallization and Salt Formation of Poorly Water-Soluble Telmisartan for Enhanced Solubility10.3390/pharmaceutics11030102 ↗
22. Continuous microchannel precipitation to enhance the solubility of telmisartan with poloxamer 407 using Box-Behnken design approach
23. Chitosan-telmisartan polymeric cocrystals for improving oral absorption: In vitro and in vivo evaluation10.1016/j.ijbiomac.2019.03.141 ↗
24. Enhanced Solubility of Telmisartan Phthalic Acid Cocrystals within the pH Range of a Systemic Absorption Site10.1021/acsomega.8b02144 ↗
25. Improved pH-dependent drug release and oral exposure of telmisartan, a poorly soluble drug through the formation of drug-aminoclay complex10.1016/j.ijpharm.2014.05.009 ↗
26. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage10.1016/j.ijpharm.2011.04.065 ↗
27. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique10.1016/j.ijpharm.2012.11.012 ↗
28. Roles of MgO release from polyethylene glycol 6000-based solid dispersions on microenvironmental pH, enhanced dissolution and reduced gastrointestinal damage of telmisartan10.1007/s12272-011-0508-2 ↗
29. Dissolution properties and physical characterization of telmisartan–chitosan solid dispersions prepared by mechanochemical activation10.1208/s12249-013-9937-1 ↗
30. Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate10.1016/j.ejps.2016.11.030 ↗
31. Solid dispersion of dutasteride using the solvent evaporation method: Approaches to improve dissolution rate and oral bioavailability in rats10.1016/j.msec.2018.04.074 ↗
32. Use of acidifier and solubilizer in tadalafil solid dispersion to enhance the in vitro dissolution and oral bioavailability in rats10.1016/j.ijpharm.2017.04.056 ↗
33. Preparation, characterization, and in vitro/vivo evaluation of polymer-assisting formulation of atorvastatin calcium based on solid dispersion technique